Financial reports
NT 10-Q
Notice of late quarterly filing
15 Nov 17
NT 10-Q
Notice of late quarterly filing
16 Aug 17
10-K
2016 FY
Annual report
21 Jul 17
NT 10-K
Notice of late annual filing
31 Mar 17
10-Q
2016 Q3
Quarterly report
29 Dec 16
NT 10-Q
Notice of late quarterly filing
15 Nov 16
10-Q
2016 Q2
Quarterly report
22 Aug 16
NT 10-Q
Notice of late quarterly filing
15 Aug 16
10-Q
2016 Q1
Quarterly report
19 May 16
NT 10-Q
Notice of late quarterly filing
17 May 16
Current reports
8-K
Calmare Therapeutics Awarded $2.5 Million, Five-year
9 Jun 20
8-K
Other Events
5 Nov 19
8-K
Departure of Directors or Certain Officers
19 Jul 19
8-K
Departure of Directors or Certain Officers
12 Jun 19
8-K
Other Events
10 Jun 19
8-K
Other Events
3 Jun 19
8-K
Calmare Therapeutics Receives Two Favorable Rulings
25 Mar 19
8-K
Other Events
18 Mar 19
8-K/A
Submission of Matters to a Vote of Security Holders
2 Jul 18
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 18
Registration and prospectus
8-A12G
Registration of securities
9 Dec 14
RW
Registration withdrawal request
14 Nov 14
S-1/A
IPO registration (amended)
13 Sep 13
S-8
Registration of securities for employees
9 Sep 13
S-1
IPO registration
22 Jul 13
S-8
Registration of securities for employees
28 Jun 13
S-8
Registration of securities for employees
5 Mar 13
S-8
Registration of securities for employees
7 Jun 12
S-8
Registration of securities for employees
24 Feb 12
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Jan 12
Proxies
DEFA14A
Additional proxy soliciting materials
2 Jul 18
DEFA14A
Additional proxy soliciting materials
15 Jun 18
DEFA14A
Additional proxy soliciting materials
4 May 18
DEFA14A
Additional proxy soliciting materials
20 Feb 18
DFAN14A
Additional proxy materials by non-management
20 Feb 18
DEFA14A
Additional proxy soliciting materials
16 Feb 18
DFAN14A
Additional proxy materials by non-management
16 Feb 18
DFAN14A
Additional proxy materials by non-management
9 Feb 18
DEFR14A
Revised proxy
16 Jan 18
PRER14A
Preliminary revised proxy
12 Jan 18
Other
REVOKED
Registration or securities revoked
17 Jul 23
UPLOAD
Letter from SEC
17 Jan 12
CT ORDER
Confidential treatment order
13 Jan 12
CT ORDER
Confidential treatment order
13 Jan 12
CT ORDER
Confidential treatment order
13 Jan 12
CORRESP
Correspondence with SEC
6 Jan 12
CORRESP
Correspondence with SEC
27 Dec 11
UPLOAD
Letter from SEC
15 Dec 11
CORRESP
Correspondence with SEC
12 Dec 11
CORRESP
Correspondence with SEC
7 Dec 11
Ownership
SC 13G/A
CALMARE THERAPEUTICS Inc
11 Feb 20
SC 13G/A
CALMARE THERAPEUTICS Inc
14 Feb 19
4
Thomas Philip Richtarich
6 Mar 18
4
Conrad F Mir
6 Mar 18
4
Peter F Brennan
6 Mar 18
SC 13G/A
CALMARE THERAPEUTICS Inc
14 Feb 18
SC 13G
CALMARE THERAPEUTICS Inc
13 Feb 18
SC 13D/A
CALMARE THERAPEUTICS Inc
21 Sep 17
SC 13D
CALMARE THERAPEUTICS Inc
30 Jun 17
SC 13G
CALMARE THERAPEUTICS Inc
14 Feb 17